Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Growth

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -157.4156.45-75.8944.4923.06

What is the latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Growth ratio of SOLARA ACTIVE PHARMA SCIENCES is -157.41 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-157.41
Mar202356.45
Mar2022-75.89
Mar202144.49
Mar202023.06

How is Core EBITDA Growth of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2024 -157.41
Negative
Mar2023 56.45
Positive
Mar2022 -75.89
Negative
Mar2021 44.49
92.93
Mar2020 23.06 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Growth ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹3,045.9 Cr -9.9% -15.2% 72.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

-9.9%

-15.2%

72.4%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses